Groups
Year
Paper
2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, Pauline Hamon, Nelson M LaMarche, Samarth Hegde, Meriem Belabed, Leanna Troncoso, John A Grout, Assaf Magen, Etienne Humblin, Achuth Nair, Martina Molgora, Jinchao Hou, Jenna H Newman, Adam M Farkas, Andrew M Leader, Travis Dawson, Darwin D'Souza, Steven Hamel, Alfonso Rodriguez Sanchez-Paulete, Barbara Maier, Nina Bhardwaj, Jerome C Martin, Alice O Kamphorst, Ephraim Kenigsberg, Maria Casanova-Acebes, Amir Horowitz, Brian D Brown, Lucas Ferrari De Andrade, Marco Colonna, Thomas U Marron, Miriam Merad.Nat Immunol. 2023 May;24(5):792-801. doi: 10.1038/s41590-023-01475-4. Epub 2023 Apr 20.
Abstract: https://pubmed.ncbi.nlm.nih.gov/37081148/
2023
A progressive T cell exhaustion program mapped across tissues in patients with lung cancer on immune checkpoint blockade
Carolina Mangana, Barbara B Maier.Cancer Cell. 2023 Apr 10;41(4):653-655. doi: 10.1016/j.ccell.2023.02.020. Epub 2023 Mar 30.
Abstract: https://pubmed.ncbi.nlm.nih.gov/37001525/
2023
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
B Fendl, A S Berghoff, M Preusser, B Maier.ESMO Open. 2023 Feb;8(1):100776. doi: 10.1016/j.esmoop.2022.100776. Epub 2023 Feb 1.
Abstract: https://pubmed.ncbi.nlm.nih.gov/36731326/